Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Hmm? Long term maybe. A pop here and there, maybe? Short term? I don’t see it!

$Envoy Medical(COCH.US)$ So this company had a pretty good device! But they stopped focusing on it to design and bring to market a better and IMO a pretty amazing device! But here is my problem! They are not really working on anything else. And dont plan on making any money until FDA approval of this new device? And at this point in the process, it wont be until 2026? COMPANYS OWN WORDS! So with the price collapse over the last year with the exception of a few pops. Patent news and such! The only way for them to stay in business, unless they get a partner? Is either financing’s or offerings? That cant bode very well for the Stonk price for the next 18+ months? Unless a surprise comes thats not in the works as of now!  But i will watch it! Hehehe
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
13
Translate
Report
4832 Views
Comment
Sign in to post a comment
  • Jaguar8 : The device is really good and is still on clinical trial. If this gets FDA and get covered by insurance it will be game changer. There is a lot of hearing-impaired in our population. The way I see the CEO telling all these prospects is to paint a good picture of it and market reacts. Still good for those who got in. Profit is profit no matter what

  • TrytosaveabitOP Jaguar8: True! I think the device is a game changer! My only problem is their financial situation! Yes it can get a PI here and there? Im more worried that it will keep trending down overall? Then the R/S will start and the offerings to get much needed cash to carry them through FDA! And I just hate seeing a company with a great product succumb to that! Here a snippet of their own words from latest 10Q/a! I did this just for you my man! Hehehe   Pay close attention to last paragraph!         Grrrrr! To long it says! I’ll post in new chat! Hehehe!

  • Jaguar8 TrytosaveabitOP: Yes also with ICCM which was practically ignored. These medical products or treatment either prolongs life or provides better quality of life and OLF. But such is the market. Can’t wait for 2026 and hopefully by that time comes, this company is still afloat.

  • TrytosaveabitOP Jaguar8: Right! Don’t know if you seen my comment earlier! I said it’s amazing VANI gets a fat helper good data and climbs 500%+! And ICCM gets 100% breast tumor reduction on woman who were inoperable! And besides a quick pop at PR release, it went down! How sick and crazy! Don’t get me wrong? I know some can’t help it! But honestly others are overweight because of lazy and diets! But cancer isn’t a choice for any! Being overweight is a choice for quite a lot! Again not all! But a lot!

  • Jaguar8 TrytosaveabitOP: I read that and you made the right point. To think that VANI is not even Phase 3 trials. It brings to my mind Ozempic which is now under scrutiny.

  • TrytosaveabitOP Jaguar8: Hehehe! Yup 35 States now have banned it for use as weight loss! They won’t pay for it unless it’s for Diabetes treatment! Not I’m fat I’ll just take a shot of a medication that people really need for disease control!

  • Jaguar8 TrytosaveabitOP: Yes the post market research on these controversial medications needed be weighed on. Same with PrEP. Lawsuits are now hounding it due to its renal effect

  • Jaguar8 TrytosaveabitOP: Indeed. Obesity is a lifestyle and culture issue. No amount of drug can really completely rid of obesity unless one decides to take charge of his or her lifestyle.  I was expecting more from ICCM since seldom I see a treatment which eradicated 100% of inoperable tumors. Oh well, it is the stock market, whatever they feel so be it

  • TrytosaveabitOP Jaguar8: Agreed! That’s why I posted, regardless of what the price does, This news is amazing!

  • Jaguar8 TrytosaveabitOP: Indeed! Kudos to ICCM for this.

View more comments...

2066Followers
31Following
25KVisitors
Follow